Galderma's Restylane Shaype Gets First Global Jawline Approval in Mexico

MT Newswires · 1d ago
02:46 AM EST, 11/13/2026 (MT Newswires) -- Galderma's (GALD.SW) Restylane Shaype received approval in Mexico for temporary chin augmentation and improved jawline definition, marking its first global approval for jawline enhancement. The approval adds to existing authorizations for chin augmentation in markets including Europe, Brazil, Canada, and Thailand, according to a Friday release. The Swiss dermatology group describes Restylane Shaype as a hyaluronic acid injectable designed to provide structural enhancement without surgery. It said a clinical study found the treatment improved jawline definition compared with no treatment, with improvements lasting up to two years.